{
    "organizations": [],
    "uuid": "d23a4dafde9618cb16404f00e6fcc3c68204a913",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cellular-biomedicine-group-reports/brief-cellular-biomedicine-group-reports-full-year-2017-financial-results-and-recent-operational-progress-idUSASB0C8ZZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Cellular Biomedicine Group Reports Full-Year 2017 Financial Results And Recent Operational Progress",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Cellular Biomedicine Group Inc:\n* CELLULAR BIOMEDICINE GROUP REPORTS FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS\n* CELLULAR BIOMEDICINE GROUP INC - HAD WORKING CAPITAL OF $20.9 MILLION AS OF DEC 31, 2017 COMPARED TO $38.3 MILLION AS OF DEC 31, 2016 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T22:29:00.000+02:00",
    "crawled": "2018-03-07T19:25:54.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "cellular",
        "biomedicine",
        "group",
        "inc",
        "cellular",
        "biomedicine",
        "group",
        "report",
        "financial",
        "result",
        "recent",
        "operational",
        "progress",
        "cellular",
        "biomedicine",
        "group",
        "inc",
        "working",
        "capital",
        "million",
        "dec",
        "compared",
        "million",
        "dec",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}